[144] Central Garden & Pet Company SEC Filing

Rhea-AI Filing Summary

Central Garden & Pet Company (CENTA) filed a Form 144 disclosing a proposed sale of 3,281 common shares, acquired as director share grants on 08/14/2024. The filing lists the broker as Morgan Stanley Smith Barney LLC and shows an aggregate market value of $109,716.64 for the shares. The company’s shares outstanding are reported as 51,618,478, and the approximate sale date is 08/14/2025 on NASDAQ. The filer reports no securities sold in the past three months for the account. The notice includes the statement that the seller represents they have no undisclosed material adverse information.

Positive

• Transparent disclosure of planned insider sale including broker, exact share count, acquisition method, and dates
• Seller representation that no undisclosed material adverse information exists
• No sales in prior three months reported for the account, clarifying aggregation history

Negative

• None.

Insights

Securities Analyst

TL;DR: Proposed director sale of 3,281 shares is disclosed; size is immaterial relative to total outstanding shares.

The filing transparently reports a planned sale through Morgan Stanley Smith Barney of 3,281 common shares with an aggregate market value of $109,716.64 and an approximate sale date of 08/14/2025. Shares were acquired as director share grants on 08/14/2024. Given the reported 51,618,478 shares outstanding, the proposed sale represents a very small fraction of the capital base. The notice also states there were no sales by the person in the prior three months, which is relevant for compliance with Rule 144 aggregation rules.

Corporate Governance Expert

TL;DR: The Form 144 documents a routine director sale tied to previously granted shares and includes the standard seller representation.

The filing identifies the nature of acquisition as "Director Share Grants" and provides the acquisition and payment date (08/14/2024). It includes the required seller representation about the absence of undisclosed material adverse information and indicates use of a named broker. This aligns with customary disclosure practices for insider sales under Rule 144 and provides investors the expected transparency on timing and broker execution.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3281	109716.64	51618478	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/14/2024	Director Share Grants	Issuer			3281	08/14/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Central Garden & Pet (CENTA) disclose in this Form 144?

The filing discloses a proposed sale of 3,281 common shares via Morgan Stanley Smith Barney LLC with an aggregate market value of $109,716.64 and an approximate sale date of 08/14/2025.

When were the shares being sold originally acquired?

The shares were acquired as Director Share Grants on 08/14/2024, with payment indicated on the same date.

How many Central Garden & Pet shares are outstanding according to the filing?

The filing reports 51,618,478 shares outstanding.

Does the filer report any securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

On which exchange is the sale expected to occur?

The sale is expected to occur on NASDAQ.